-
FDA Clears Targeted Breast Cancer Radiation Treatment
The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby.
-
Merry Christmas from Science & Enterprise
Science & Enterprise will continue its regular posting on Wednesday, 27 December.
-
Retinal Scanner Detects Early Vision Problems
A Canadian engineering lab designed a retinal scanner that helps diagnose eye diseases in their early stages, often well before vision loss occurs.
-
Phone Sensors Shown to Monitor Chemotherapy Effects
21 December 2017. A group of cancer patients was able to monitor the severity of effects of their chemotherapy with built-in sensors on smartphones and fitness trackers. Results of the clinical study, led by researchers at University of Pittsburgh, appear in the 19 December issue of the Journal of Medical Internet Research. The team from Pittsburgh’s…
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.
-
Finland Begins Large-Scale National Genomic Study
The country of Finland is conducting a nationwide genomic analysis of its population, collecting 500,000 blood samples from its 5.5 million citizens.
-
FDA Approves Gene Therapy for Inherited Vision Loss
A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration.
-
Super High-Resolution Photo Sensor Developed
Engineers at Dartmouth College developed a sensor that captures light signals at high speed and resolution down to the level of individual photons.
-
Agriculture Tech Start-Up Accelerator to Open
A group supporting start-up companies and entrepreneurs developing new technologies in food and agriculture plans to begin next month in Minneapolis, Minnesota.
-
Biotechs Partner on HPV Cancer Immunotherapies
Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV.